X T L Biopharmaceuticals

XTLB · TEL

$2.02+$0.05 (+2.54%)TodayMarket closed ·
Prev close $1.97

Key indicators

XTLB profitability and balance sheet ratios

EPS -$0.0055 in Jun 2019, down 5600.0% on a year earlier.

EPS by quarter
PeriodEPS
Dec 2016-$0.0032
Dec 2017$0.00
Mar 2018$0.0017
Jun 2018$0.0001
Sep 2018$0.002
Dec 2018$0.002
Mar 2019$0.0075
Jun 2019-$0.0055

Income statement

No financial statements are reported for X T L Biopharmaceuticals.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.